GlassScriptPhysician profile
George Wong
NPI 1508801333
$8,469.99
in general payments reported to CMS, 2019-2025
40 companies · none reported in 2025
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,562 · 2020: $2,396 · 2021: $512.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mdd US Operations, LLC | $6,542.62 | 2019-2020 | |
| Supernus Pharmaceuticals, INC. | $302.43 | 2020-2021 | |
| Genzyme Corporation | $151.94 | 2019-2021 | |
| Allergan, INC. | $139.38 | 2019-2021 | |
| Abbvie INC. | $116.43 | 2019-2021 | |
| Emd Serono, INC. | $115.02 | 2020-2021 | |
| Acadia Pharmaceuticals INC | $112.75 | 2019-2021 | |
| Kyowa Kirin, INC. | $111.73 | 2019-2021 | |
| Amgen INC. | $94.72 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $79.24 | 2019-2020 | |
| Ucb, INC. | $54.37 | 2019-2021 | |
| Boston Scientific Corporation | $53.88 | 2019-2021 | |
| Sunovion Pharmaceuticals INC. | $52.72 | 2019-2020 | |
| Teva Pharmaceuticals USA, INC. | $44.75 | 2019-2021 | |
| Piramal Critical Care | $40.05 | 2019-2020 |
Show all 40 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neurocrine Biosciences, INC. | $36.12 | 2019-2020 | |
| Biogen, INC. | $32.40 | 2020 | |
| Pfizer INC. | $32.03 | 2019-2021 | |
| Jazz Pharmaceuticals INC. | $29.77 | 2020-2021 | |
| Adamas Pharmaceuticals, INC. | $28.79 | 2019-2021 | |
| Medtronic Vascular, INC. | $25.34 | 2020 | |
| Lundbeck LLC | $18.86 | 2019 | |
| Merz North America, INC. | $17.09 | 2020 | |
| Alnylam Pharmaceuticals INC. | $16.91 | 2021 | |
| Csl Behring | $16.63 | 2019 | |
| Bausch Health US, LLC | $16.42 | 2019 | |
| Alexion Pharmaceuticals, INC. | $15.99 | 2020 | |
| E.R. Squibb & Sons, L.L.C. | $15.38 | 2020 | |
| Portola Pharmaceuticals, LLC | $15.14 | 2019 | |
| Tanabe Pharma America, INC. | $14.97 | 2019 | |
| Biohaven Pharmaceuticals, INC. | $14.41 | 2020 | |
| Janssen Pharmaceuticals, INC | $14.29 | 2020 | |
| Amneal Pharmaceuticals LLC | $14.25 | 2020 | |
| Livanova USA, INC. | $13.81 | 2019 | |
| Lilly USA, LLC | $12.79 | 2019 | |
| Eisai INC. | $12.78 | 2020 | |
| Sk Life Science, INC. | $12.71 | 2021 | |
| Banner Life Sciences, LLC | $11.49 | 2021 | |
| Strongbridge US INC. | $11.41 | 2019 | |
| Ambu INC. | $8.18 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw George Wong listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.